No need debate about the huge potential of Buddy...
Just wonder if anyone can shed light on the favorite one mentioned at the end of the quoted article "Our favourite – a tiny Aussie partnering with giants
Our third stock is, hands down, our favourite. It’s a tiny Aussie medical tech company with a market cap of just $126 million. But it’s already a leader in developing and commercializing computerized solutions for brain function measurement and analysis. In fact, it works with nine of the top 10 global pharmaceutical companies, such as Pfizer, Johnson & Johnson, and Lilly and Merck...."
- Forums
- ASX - By Stock
- BUD
- Ann: Change of Director's Interest Notice x 4
Ann: Change of Director's Interest Notice x 4, page-34
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)